We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Online Tool Helps Validate Clinical Molecular Assays

By LabMedica International staff writers
Posted on 08 Dec 2010
A new online tool helps clinical laboratories standardize their verification and validation requirements and eases adoption of new molecular tests.

The web-based program is designed to assist laboratories in identifying molecular assay verification or validation requirements to comply with clinical laboratory improvement amendments (CLIA) accreditation requirements in the United States and meet International Standards Organization (ISO) standards in Europe. Compliance with CLIA requirements is necessary for any laboratory that reports patient results for clinical purposes in the United States.

The EZValidation Online Tool, which was launched by Life Technologies' (Carlsbad, CA, USA) and configured to work with the company's AcroMetrix quality control materials, helps labs establish an easy-to-use workflow from protocol development through the final report generation. The tool provides a simplified path for adopting new molecular assays through ISO 15189, CLIA, College of American Pathologists (CAP) and New York State guidelines. The online tool is also updateable for new guidelines and tests as they are developed.

Kimberlee Caple, head of Molecular Medicine Products at Life Technologies said, "EZValidation's Online Tool will help clinical labs maintain their compliance and adopt new molecular tests to foster the accuracy, reliability, and timeliness of patients' results." She added, "The clinical laboratory market is the front line for the adoption of molecular medicine in healthcare, and EZValidation helps those facilities incorporate molecular assays more efficiently, accurately and effectively."

Related Links:
Life Technologies



New
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Unit-Dose Packaging solution
HLX
New
Bordetella Pertussis ELISA
NovaLisa Bordetella Pertussis IgA
New
Vedolizumab ELISA
RIDASCREEN VDZ Monitoring

Latest Molecular Diagnostics News

POC Sepsis Test Delivers Fast, Accurate and User-Friendly Results in Critical Care Settings

Experimental Blood Test Improves Detection of Early-Stage Pancreatic Cancer

Simple Blood Draw Helps Diagnose Lung Cancer 10 Times Faster